Clinical Trials Logo
  1. Home
  2. Chronic Kidney Disease
  3. NCT03246191
  4. Details
NCT03246191 Clinical Trial

Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease

Chronic Kidney Disease Clinical Trial

Official title:
Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease：a Cross - Sectional Study

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT03246191
Other study ID # 2015BAI12B06-2
Secondary ID
Status Not yet recruiting
Phase N/A
First received June 13, 2017
Last updated August 8, 2017
Start date August 2017
Est. completion date May 2018

Study information
Verified date August 2017
Source Chinese PLA General Hospital
Contact guangyan cai
Phone 00861066935462
Email caiguangyan@sina.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study is an observational, cross-sectional study aimed at screening and accessing risk factors and complications for Chinese chronic kidney disease (CKD) patients. To investigate the prevalence of hypertension, cardiovascular and cerebrovascular diseases, protein energy malnutrition（PEM）, cognitive impairment and other complications in the CKD patients. To develop biomarkers of CKD.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 900
Est. completion date May 2018
Est. primary completion date May 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- age=18 years

- clinical diagnosis of CKD

- signed informed consent

Exclusion Criteria:

- End-stage renal disease(ESRD) or dialysis

- Acute kidney injure(AKI)

- history of solid organ or bone marrow transplantation

- active malignancy within 24 months prior to screening or metastatic cancer

- HIV infection or AIDS

- acute inflammation

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• blood sample collection
blood sample collection

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Chinese PLA General Hospital

Outcome
Type Measure Description Time frame Safety issue
Primary Prevalence of CKD complications hypertension, cardiovascular and cerebrovascular diseases, protein energy malnutrition(PEM), cognitive impairment baseline
Primary Biomarkers of kidney function baseline
Secondary Genetic analyses circulating microRNA baseline
Secondary Questionnaire assessing cognitive function Montreal Cognitive Assessment-Basic Chinese Version baseline
Secondary Questionnaire assessing depression Beck Depression Inventory scores baseline
Secondary Questionnaire assessing risk of malnutrition Malnutrition-Inflammation Score baseline
Secondary Questionnaire assessing dietary intake Food Frequency Questionnaire baseline
Secondary Questionnaire assessing quality of life Activity of daily living(ADL)and kidney disease quality of life (KDQOLTM-36) baseline
See also
  Status Clinical Trial Phase
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Terminated NCT04043026 - The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
Completed NCT05318014 - Low-protein Formula Supplements in Chronic Kidney Disease N/A
Active, not recruiting NCT06071065 - Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients N/A
Completed NCT02878317 - Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
Not yet recruiting NCT06039254 - Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function Phase 1
Recruiting NCT03160326 - The QUALITY Vets Project: Muscle Quality and Kidney Disease
Completed NCT02836574 - A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease Phase 2
Withdrawn NCT02885545 - The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial Phase 4
Completed NCT02756520 - Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
Completed NCT02896309 - The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity N/A
Completed NCT02875886 - DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease Phase 4
Completed NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency N/A
Active, not recruiting NCT02483039 - Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization N/A
Completed NCT02992548 - Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease Phase 4
Completed NCT02369549 - Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease Phase 3
Terminated NCT02543177 - Optimised Procedure in Patients With NSTEMI and CKD N/A
Recruiting NCT02205944 - Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes N/A
Active, not recruiting NCT02231138 - Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease Phase 4